P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847724.59361.c7 |
| _version_ | 1797285971686850560 |
|---|---|
| author | R. Cordoba L. Falchi T. Phillips S. de Vos M. Nijland F. Offner I. Bykhovski J. Wu L. Wang A. Rana P. Abrisqueta |
| author_facet | R. Cordoba L. Falchi T. Phillips S. de Vos M. Nijland F. Offner I. Bykhovski J. Wu L. Wang A. Rana P. Abrisqueta |
| author_sort | R. Cordoba |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:10:45Z |
| format | Article |
| id | doaj.art-f1ef728590fa46b3b1e0637910ffc03d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:10:45Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-f1ef728590fa46b3b1e0637910ffc03d2024-03-02T07:47:22ZengWileyHemaSphere2572-92412022-06-0161101110210.1097/01.HS9.0000847724.59361.c7202206003-01101P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTR. Cordoba0L. Falchi1T. Phillips2S. de Vos3M. Nijland4F. Offner5I. Bykhovski6J. Wu7L. Wang8A. Rana9P. Abrisqueta101 Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain2 Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York3 University of Michigan Comprehensive Cancer Center, Ann Arbor4 Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, United States of America5 University Medical Center Groningen and University of Groningen, Groningen, Netherlands6 Universitair Ziekenhuis Gent, Ghent, Belgium7 Genmab, Princeton8 AbbVie, North Chicago, United States of America7 Genmab, Princeton7 Genmab, Princeton9 Hospital Universitario Vall d’Hebron, Barcelona, Spainhttp://journals.lww.com/10.1097/01.HS9.0000847724.59361.c7 |
| spellingShingle | R. Cordoba L. Falchi T. Phillips S. de Vos M. Nijland F. Offner I. Bykhovski J. Wu L. Wang A. Rana P. Abrisqueta P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT HemaSphere |
| title | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_fullStr | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full_unstemmed | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_short | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_sort | p1215 preliminary phase 1 2 results of subcutaneous epcoritamab r dhax c in patients with relapsed or refractory diffuse large b cell lymphoma eligible for autologous stem cell transplant |
| url | http://journals.lww.com/10.1097/01.HS9.0000847724.59361.c7 |
| work_keys_str_mv | AT rcordoba p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT lfalchi p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT tphillips p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT sdevos p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT mnijland p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT foffner p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT ibykhovski p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT jwu p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT lwang p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT arana p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT pabrisqueta p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant |